The Potential of Continuous Processing in Secondary Manufacturing
1
Siemens Headquarters Pharma, Antwerp, Belgium
2
Siemens Industrial Automations and Druves Technology, Antwerp, Belgium
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 562; https://doi.org/10.3797/scipharm.cespt.8.LPES01
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Pharmaceutical secondary manufacturing has long stood in stark contrast to the drug discovery end of the business, as well as to other sectors, when it comes to innovation such as continuous manufacturing. [...]
Share and Cite
MDPI and ACS Style
VANGENECHTEN, R.; BACKX, I. The Potential of Continuous Processing in Secondary Manufacturing. Sci. Pharm. 2010, 78, 562. https://doi.org/10.3797/scipharm.cespt.8.LPES01
AMA Style
VANGENECHTEN R, BACKX I. The Potential of Continuous Processing in Secondary Manufacturing. Scientia Pharmaceutica. 2010; 78(3):562. https://doi.org/10.3797/scipharm.cespt.8.LPES01
Chicago/Turabian StyleVANGENECHTEN, R., and I. BACKX. 2010. "The Potential of Continuous Processing in Secondary Manufacturing" Scientia Pharmaceutica 78, no. 3: 562. https://doi.org/10.3797/scipharm.cespt.8.LPES01
